981 resultados para CA-19.9
Resumo:
The study was conducted to evaluate six K:Ca:Mg ratios for production of two cultivars of mini tomato grown in substrate, in a greenhouse, during two growing seasons. The experimental design was randomized blocks with four replications and twelve treatments using both cultivars of mini tomato (Sweet Million and Sweet Grape) and six K:Ca:Mg ratios (4:3:1, 6:3:1, 6:4.5:1, 2.7:3:1, 2.7:2:1, 4:2:1) in nutrient solutions. In both experiments, nutrient solutions with the highest concentrations of Mg, (75 mg L-1) and the lowest concentrations of Ca, (150 mg L-1) led to the highest concentrations of those nutrients in plant dry matter. The Sweet Million cultivar had higher yield (1.69 kg plant-1 and 1.52 kg plant-1), number of fruits per plant (227 and 236), and water use efficiency (29.1 kg m-3 and 25.3 kg m-3). However, the Sweet Grape cultivar had fruits of higher mean weight (9.0 g and 8.8 g) and macronutrient content in the leaves. In both crop cycles, the different K:Ca:Mg ratios affected only the macronutrient contents of the mini tomato plants grown in substrate, with no effect on yield and water use efficiency. The first crop cycle showed the highest N, K, Ca and S content.
Resumo:
Abnormal matrix metalloproteinase (MMP)-9 levels may have a role in hypertensive disorders of pregnancy. We examined whether MMP-9 genetic polymorphisms (g.-1562C>T and g.-90(CA)(13-25)) modify plasma MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 levels and the responses to antihypertensive therapy in 214 patients with preeclampsia (PE), 185 patients with gestational hypertension (GH) and a control group of 214 healthy pregnant (HP). Alleles for the g.-90(CA)(13-25) polymorphism were grouped L (low) (<21 CA repeats) or H (high) (>= 21 CA repeats). Plasma MMP-9 and TIMP-1 concentrations were measured by enzyme-linked immunosorbent assay. Plasma MMP-9 concentrations were not affected by genotypes or haplotypes in HP and PE groups, except for the g.-90(CA)(13-25) polymorphism: GH patients with the LH genotype for this polymorphism have higher MMP-9 levels than those with other genotypes. The T allele for the g.-1562C>T polymorphism and the H4 haplotype (combining T and H alleles) are associated with GH and lack of responsiveness to antihypertensive therapy in GH. The H2 haplotype (combining C and H alleles) was associated with lack of responsiveness to antihypertensive therapy in PE, but not in GH. In conclusion, our results show that MMP-9 genetic variants are associated with GH and suggest that MMP-9 haplotypes affect the responsiveness to antihypertensive therapy in hypertensive disorders of pregnancy. The Pharmacogenomics Journal (2012) 12, 489-498; doi: 10.1038/tpj.2011.31; published online 19 July 2011
Resumo:
Bibliograph. Nachweis: Paas P-2061